CanSino Biologics Inc. (OTCMKTS:CASBF) Short Interest Down 46.0% in January

CanSino Biologics Inc. (OTCMKTS:CASBF) saw a large decline in short interest during the month of January. As of January 15th, there was short interest totalling 10,800 shares, a decline of 46.0% from the December 31st total of 20,000 shares. Based on an average daily trading volume, of 400 shares, the days-to-cover ratio is currently 27.0 days.

CanSino Biologics Stock Performance

CASBF opened at C$3.37 on Wednesday. CanSino Biologics has a fifty-two week low of C$1.86 and a fifty-two week high of C$4.35. The firm has a 50-day moving average of C$3.83 and a 200 day moving average of C$3.18.

CanSino Biologics Company Profile

CanSino Biologics Inc develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.